|
Tuesday, November 15, 2016
Print Current Day:
 |
|
| SESSION 1 SCHEDULE | |
|
Tuesday
SESSION 1:
PROGRESS IN HEART VALVES, AORTIC AND CAROTID DISEASES AND THEIR TREATMENT
Moderators:Nicholas J.W. Cheshire, MD / Hazim J. Safi, MD
|
|
| x | |
| 6:45 AM - 6:49 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:50 AM - 6:55 AM | Current Status Of Transcatheter Aortic Valve Implantation (TAVI): A Cardiac Surgeon’s Perspective |
| Presenter(s):Allan Stewart, MD | |
| View Slides in PDF | |
| 6:56 AM - 7:01 AM | Current Status Of TAVI And What Is Beyond The Sapien And Core Valves: An Interventional Cardiologist’s Perspective |
| Presenter(s):Dietmar H. Koschyk, MD | |
| View Slides in PDF | |
| 7:02 AM - 7:07 AM | Transcatheter Mitral Valve Repair: Current Status And Devices |
| Presenter(s):Lars G. Svensson, MD, PhD | |
| View Slides in PDF | |
| ASCENDING AORTIC ENDOGRAFTING | |
| 7:08 AM - 7:13 AM | Early Experience With Gore Endovascular Device For Type A Dissections: Advantages And Limitations |
| Presenter(s):Michael J. Reardon, MD | |
| View Slides in PDF | |
| 7:14 AM - 7:19 AM | Current And Future Role Of Endovascular Grafts For The Ascending Aorta And Aortic Root |
| Presenter(s):Grayson H. Wheatley, MD | |
| View Slides in PDF | |
| 7:20 AM - 7:25 AM | Advances And Limitations With Endograft Treatment Of Ascending Aortic Lesions |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 7:26 AM - 7:31 AM | Promises And Current Limitations Of Ascending Aortic Endograft Treatment |
| Presenter(s):Ralf R. Kolvenbach, MD | |
| View Slides in PDF | |
| 7:32 AM - 7:37 AM | Progress With Ascending Aortic Endograft Treatment: What Lesions, Indications, Techniques And Results |
| Presenter(s):Carlos E. Donayre, MD / Rodney A. White, MD | |
| View Slides in PDF | |
| 7:38 AM - 7:43 AM | Panel Discussion |
| END OF SESSION 1 | |
| SESSION 2 SCHEDULE | |
|
Tuesday
SESSION 2:
NEW DEVELOPMENTS IN TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
Moderators:Lars G. Svensson, MD, PhD / Timothy A.M. Chuter, DM
|
|
| x | |
| 7:44 AM - 7:49 AM | What Is A Frozen Elephant Trunk Procedure: What Is Its Value In Thoracic Aortic Disease And Does The Vascutek Thoraflex Hybrid Graft Facilitate The Procedure |
| Presenter(s):Joseph S. Coselli, MD / Ourania Preventza, MD | |
| View Slides in PDF | |
| 7:50 AM - 7:55 AM | Status Of Open Repair For Complicated Type B Aortic Dissections (TBADs): It Is Still The Best Treatment If Certain Conditions Apply |
| Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD | |
| View Slides in PDF | |
| 7:56 AM - 8:01 AM | Hybrid Repair Of Aortic Arch Aneurysms And Dissections Is The Best Treatment Option In Fit Patients |
| Presenter(s):Roberto Chiesa, MD / Germano Melissano, MD | |
| View Slides in PDF | |
| 8:02 AM - 8:07 AM | Hybrid Approaches To Aortic Arch Lesions: What Is Their Role And Value |
| Presenter(s):Eric E. Roselli, MD | |
| View Slides in PDF | |
| 8:08 AM - 8:13 AM | Endovascular Arch Repair After Open Repair Of Type A Aortic Dissection (TAAD): Indications, Precautions And Results |
| Presenter(s):Stephan Haulon, MD | |
| View Slides in PDF | |
| 8:14 AM - 8:19 AM | Techniques For And Long-Term Results Of Treating Zone 0 Aortic Arch Lesions Endovascularly: Including The Use Of Bolton’s Branched TEVAR Device |
| Presenter(s):Toru Kuratani, MD, PhD | |
| View Slides in PDF | |
| 8:20 AM - 8:25 AM | Thoracic Single Endobranch Endograft (Gore TAG) For Treating Arch Aneurysms In Zones 0, 1 And 2: Technique, Advantages, Limitations And Early Results |
| Presenter(s):Michel Makaroun, MD / Michael D. Dake, MD | |
| View Slides in PDF | |
| 8:26 AM - 8:31 AM | Update On Mona LSA Single Branched Graft (Medtronic) For Revascularization Of The Left Subclavian Artery With TEVAR: Advantages And Results |
| Presenter(s):Frank R. Arko, MD / Eric E. Roselli, MD | |
| View Slides in PDF | |
| 8:32 AM - 8:37 AM | Endovascular Treatment Of Aortic Arch Lesions With Chimney Grafts And The Nexus Fenestrated Endograft |
| Presenter(s):Mario L. Lachat, MD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:38 AM - 8:43 AM | Tips And Tricks To Make Chimney TEVAR (Ch/TEVAR) In The Aortic Arch Successful |
| Presenter(s):Chang Shu, MD | |
| View Slides in PDF | |
| 8:44 AM - 8:50 AM | Panel Discussion |
| END OF SESSION 2 | |
| SESSION 3 SCHEDULE | |
|
Tuesday
SESSION 3:
TYPE B AORTIC DISSECTIONS (TBADs) AND THEIR TREATMENT: INCLUDING SECONDARY THORACOABDOMINAL ANEURYSMS (TAAAs)
Moderators:Joseph S. Coselli, MD / Michel Makaroun, MD
|
|
| x | |
| 8:51 AM - 8:56 AM | New Developments In The Treatment Of TBADs: Where Are We Headed |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 8:57 AM - 9:02 AM | Best Medical Treatment For Uncomplicated TBAD: Factors Predicting Need For TEVAR And Significance Of Aortic Arch Tears |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 9:03 AM - 9:08 AM | Predictors Of Need For Intervention (TEVAR, Etc.) And Mortality With Uncomplicated Acute TBAD: Total Aortic Diameter >44 mm Matters Most |
| Presenter(s):Ali Azizzadeh, MD / Anthony L. Estrera, MD / Hazim J. Safi, MD | |
| View Slides in PDF | |
| 9:09 AM - 9:14 AM | Natural History Of TEVAR Treated TBADs: One-Third Of TEVAR Treated Patients Don’t Remodel And Develop Aneurysms – Usually In Thoracic Aorta: How To Treat And Prevent Rupture |
| Presenter(s):Tilo Koelbel, MD, PhD / Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 9:15 AM - 9:20 AM | 5-Year Update Of STABLE I And 2-Year Update Of STABLE II Trials Of 2-Component TEVAR With Proximal Covered And Distal Bare Stents (Petticoat Concept) For Acute TBADs: Are There Advantages And Limitations |
| Presenter(s):Joseph V. Lombardi, MD | |
| View Slides in PDF | |
| 9:21 AM - 9:26 AM | Advantage Of The 2-Component Petticoat System: Overdilatation Of The Bare Stent Can Disrupt The Dissection Flap And Facilitate Distal False Lumen Obliteration Improving Outcomes With Acute TBADs: Technique And Results |
| Presenter(s):Jean-Marc Alsac, MD, PhD | |
| View Slides in PDF | |
| 9:27 AM - 9:32 AM | Distal Extended Branched Petticoat Technique To Treat False Lumen Aneurysms From Complex Aortic Dissections: How To Do It And Results |
| Presenter(s):Lars R. Kock, MD | |
| View Slides in PDF | |
| 9:33 AM - 9:38 AM | Disadvantages Of The Petticoat Technique: Why It May Not Be Beneficial |
| Presenter(s):Ludovic Canaud, MD, PhD | |
| View Slides in PDF | |
| 9:39 AM - 9:44 AM | Tips And Tricks To Avoid Pitfalls In The TEVAR Treatment Of TBADs |
| Presenter(s):Weiguo Fu, MD | |
| View Slides in PDF | |
| 9:45 AM - 9:50 AM | Open Surgery Is The Best Treatment For Thoracoabdominal Aneurysms (TAAAs) Complicating TBADs |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 9:51 AM - 9:57 AM | Panel Discussion |
| 9:58 AM - 10:10 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 3 | |
| SESSION 4 SCHEDULE | |
|
Tuesday
SESSION 4:
MORE ABOUT NEW DEVELOPMENTS IN THE TREATMENT OF TBADs AND RELATED ENTITIES
Moderators:Christoph A. Nienaber, MD, PhD / Frank J. Veith, MD
|
|
| x | |
| 10:10 AM - 10:15 AM | Natural History Of Penetrating Ulcers In The Thoracic Aorta: When Should They Be Treated Conservatively And When By TEVAR |
| Presenter(s):Thomas C. Bower, MD | |
| View Slides in PDF | |
| 10:16 AM - 10:21 AM | Natural History Of Intramural Hematomas In The Thoracic Aorta: When Should They Be Treated Conservatively And When By TEVAR |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 10:22 AM - 10:27 AM | How To Follow TBAD Patients On Medical Treatment And After TEVAR: What Secondary Interventions May Be Required And When |
| Presenter(s):Götz M. Richter, MD, PhD | |
| View Slides in PDF | |
| 10:28 AM - 10:33 AM | Detecting False Lumen Thrombosis In TBAD Patients: It Is Not So Easy: What Technique Is Most Reliable |
| Presenter(s):Rachel E. Clough, MD, PhD | |
| View Slides in PDF | |
| 10:34 AM - 10:39 AM | DEBATE: When Performing TEVAR For Acute Uncomplicated TBAD, The Procedure Should Be Delayed 2-12 Weeks (~6 Weeks) After The Event To Decrease Chances Of Retrograde Dissection |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 10:40 AM - 10:45 AM | DEBATE: It Is Safe To Perform TEVAR For Uncomplicated TBAD Within <2 Weeks Of The Acute Event If Certain Precautions Are Taken |
| Presenter(s):Jan S. Brunkwall, MD, PhD | |
| View Slides in PDF | |
| 10:46 AM - 10:51 AM | 4-Year Results With Bolton Relay Graft For TEVAR And New Modifications Of The Platform Including Proximal And Distal Scallops And Ways To Prevent Proximal Migration |
| Presenter(s):Vicente Riambau, MD, PhD | |
| View Slides in PDF | |
| 10:52 AM - 10:57 AM | Why Patients With TBAD Can Benefit From Dissection Flap Disruption (Septotomy): How It Can Be Done Safely And A Device To Do It |
| Presenter(s):Ramon Berguer, MD, PhD / Juan C. Parodi, MD | |
| View Slides in PDF | |
| 10:58 AM - 11:04 AM | Panel Discussion |
| Moderator(s): Hazim J. Safi, MD / Roberto Chiesa, MD | |
| 11:04 AM - 11:09 AM | There Is No Such Thing As A Chronic TBAD: Why Our Thinking And Nomenclature Should Change |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 11:10 AM - 11:15 AM | Staged Hybrid Procedure (Proximal TEVAR And Open Distal TAAA Repair) Is A Better Way To Treat TBAD With Extensive TAAA: Technique, Advantages And Limitations |
| Presenter(s):Gilbert R. Upchurch, MD | |
| View Slides in PDF | |
| 11:16 AM - 11:21 AM | False Lumen Outflow Resistance As A Predictor Of The Need For Late Reintervention With Uncomplicated TBAD: How To Measure And What To Do With This Measurement |
| Presenter(s):Geert Willem H. Schurink, MD, PhD / Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 11:22 AM - 11:27 AM | Expanding Midterm Experience With Fenestrated And Branched EVAR (F/BEVAR) For TAAAs From Chronic TBADs: Advantages And Limitations |
| Presenter(s):Eric L.G. Verhoeven, MD, PhD / Piotr M. Kasprzak, MD | |
| View Slides in PDF | |
| 11:28 AM - 11:33 AM | TEVAR Endografts For TBADs Can Cause New Distal Entry Tears: How To Detect And Treat Them |
| Presenter(s):Chun Che Shih, MD, PhD | |
| View Slides in PDF | |
| 11:34 AM - 11:39 AM | Application Of Occlusive Devices In The Endovascular Treatment Of Difficult Aortic Lesions (Dissections And False Aneurysms) Unsuitable For Endograft Repair |
| Presenter(s):Guangqi Chang, MD | |
| View Slides in PDF | |
| 11:40 AM - 11:45 AM | Peripheral Vascular Complications Of TEVAR And TAVI: How To Prevent And Treat Them |
| Presenter(s):Ali Khoynezhad, MD, PhD | |
| View Slides in PDF | |
| 11:46 AM - 11:51 AM | What Proportion Of Strokes With TEVAR Are Due To Air Emboli And Not Particulate Emboli: CO2 Flushing Of Devices Can Prevent Air Embolic Strokes |
| Presenter(s):Tilo Koelbel, MD, PhD / Sebastian E. Debus, MD, PhD | |
| View Slides in PDF | |
| 11:52 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 4 | |
| SESSION 5 SCHEDULE | |
|
Tuesday
SESSION 5:
NEW KEY DEVELOPMENTS IN THE MANAGEMENT OF PATIENTS WITH CAROTID DISEASE
Moderators:Frank J. Veith, MD / Klaus D. Mathias, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Endovascular Repair Of Saccular Aneurysms Of The Extracranial Internal Carotid Artery Is No Longer Hazardous But Fusiform Aneurysms Remain A Challenge: Tips And Tricks: Long-Term Results |
| Presenter(s):James May, MD, MS, FRACS, FACS | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Value Of OCT And IVUS Evaluation Before And After CAS: How Can They Improve Results |
| Presenter(s):Carlo Setacci, MD / Bernhard Reimers, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Optimal Medical Management To Decrease Cardiovascular And Stroke Risk As In The SAMMPRIS Trial: It Is Not Simple And Requires Training: How To Do It And What Are The Treatment Goals |
| Presenter(s):Colin P. Derdeyn, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | Despite Level 1 Evidence To The Contrary, Patches Are Not Always Necessary With CEA And Patches Can Cause Serious Complications: How To Avoid Patch Closures |
| Presenter(s):Robert B. McLafferty, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | With High-Grade Asymptomatic Carotid Stenosis (ACS) There Is A Low Rate Of Occlusion And Stroke In Patients On Current Best Medical Therapy (BMT) |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | DEBATE: The 10-Year CREST Trial Results Indicate That CAS Is Equivalent To CEA In Both Symptomatic And Asymptomatic Carotid Stenosis Patients |
| Presenter(s):Thomas G. Brott, MD / Brajesh K. Lal, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | DEBATE: Not So Fast: There Are Other Ways To Interpret The 10-Year Results From CREST |
| Presenter(s):J. David Spence, MD | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | How Best To Manage Acute Carotid Occlusion After CEA: Why Endovascular Treatment Can Be The Best Option |
| Presenter(s):Alejandro M. Spiotta, MD | |
| View Slides in PDF | |
| 1:48 PM - 1:54 PM | Panel Discussion |
| Moderator(s): Claudio J. Schonholz, MD / L. Nelson Hopkins, MD | |
| 1:54 PM - 1:59 PM | DEBATE: 5-Year Results From The ACT-1 Trial Show That CAS Is Equivalent To CEA For Asymptomatic Carotid Stenosis (ACS) |
| Presenter(s):Kenneth Rosenfield, MD / Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 2:00 PM - 2:05 PM | DEBATE:Not So Fast: There Is Another Interpretation To ACT-1: It Does Not Change Current Evidence That BMT Alone Is Best For Asymptomatic Carotid Stenosis |
| Presenter(s):Anne L. Abbott, MD, PhD, FRACP | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Systemic Biomarkers Can Predict The Stroke Risk Of Carotid Plaques And Cognitive Decline After CEA And CAS: Are There Differences Between The 2 Procedures |
| Presenter(s):Wei Zhou, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | DEBATE: How To Identify Those ACS Patients Who Can Benefit From An Invasive Intervention (CEA Or CAS): What Is That Percentage Of ACS Patients |
| Presenter(s):Andrew N. Nicolaides, MS, FRCS | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | DEBATE: The Rationale For A Differing Viewpoint: What Percentage Of ACS Patients Should Be Treated Invasively And Why CEA Is The Best Treatment |
| Presenter(s):Bruce A. Perler, MD, MBA | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | In Light Of The 10-Year CREST Results And The 5-Year ACT-1 Results, How Should We Regard The Future Of CAS For Symptomatic And Asymptomatic Carotid Stenosis Patients: A UK And European Perspective |
| Presenter(s):Ross Naylor, MD, FRCS | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | In Light Of The 10-Year CREST And 5-Year ACT-1 Results How Should We Regard The Future Of CAS For Symptomatic And Asymptomatic Carotid Stenosis: A US Perspective |
| Presenter(s):Jon S. Matsumura, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:42 PM | Panel Discussion |
| 2:42 PM - 2:55 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 5 | |
| SESSION 6 SCHEDULE | |
|
Tuesday
SESSION 6:
INVASIVE TREATMENT FOR AND AFTER ACUTE STROKES
Moderators:L. Nelson Hopkins, MD / Sriram S. Iyer, MD, FACC
|
|
| x | |
| 2:55 PM - 3:00 PM | Emergency Management Of Acute Strokes: What Can Be Done Intracranially And At the Carotid Bifurcation: How To Do CAS Safely In The Acute Setting |
| Presenter(s):Klaus D. Mathias, MD | |
| View Slides in PDF | |
| 3:01 PM - 3:06 PM | Set Up Of An Organization Within A Hospital To Treat An Acute Stroke: To Determine If Intervention At Carotid Or Intracranial Levels Is Appropriate And To Do So Rapidly |
| Presenter(s):Luigi Inglese, MD | |
| View Slides in PDF | |
| 3:07 PM - 3:12 PM | Update On Positive Randomized Controlled Trials (RCTs) Of Intracranial Clot Removal For Stroke: How To Select Patients Currently: Should Indications Be Broadened And Ongoing RCTs |
| Presenter(s):L. Nelson Hopkins, MD | |
| View Slides in PDF | |
| 3:13 PM - 3:18 PM | Improvements In Intracranial Clot Removal By Direct Aspiration For Acute Strokes: Technique, Equipment And Results: What Does The Future Hold For Stroke Endovascular Therapy |
| Presenter(s):Alejandro M. Spiotta, MD | |
| View Slides in PDF | |
| 3:19 PM - 3:24 PM | Advantages Of Direct Carotid Access (Percutaneous Or By Open Exposure) For Acute Ischemic Stroke Intervention At Carotid Or Intracranial Levels |
| Presenter(s):Mark H. Wholey, MD | |
| View Slides in PDF | |
| URGENT CAROTID TREATMENT (SEE SESSION 75 FOR MORE RELATED TOPICS) | |
| 3:25 PM - 3:30 PM | DEBATE: Urgent CEA Within 1 Week After A Stroke Or TIA Is Relatively Safe Whereas Urgent CAS Is Generally Not Safe |
| Presenter(s):Gustav Fraedrich, MD | |
| View Slides in PDF | |
| 3:31 PM - 3:36 PM | DEBATE: CEA Within 48 Hours Of Symptom Onset Is Not Safe: Best To Delay CEA For Two Weeks But The Evidence Is Mixed |
| Presenter(s):Martin Bjorck, MD, PhD | |
| View Slides in PDF | |
| 3:37 PM - 3:42 PM | Urgent Carotid Interventions For Acute Stroke: CEA vs. CAS: When And When Not To Intervene: CT Perfusion Studies Can Help In Decision Making |
| Presenter(s):Hernan Bazan, MD, FACS | |
| View Slides in PDF | |
| 3:43 PM - 3:49 PM | Panel Discussion |
| END OF SESSION 6 | |
| SESSION 7 SCHEDULE | |
|
Tuesday
SESSION 7:
MORE NEW DEVELOPMENTS IN TEVAR, TAAA AND TBAD TREATMENTS
Moderators:Mark A. Farber, MD / Stephan Haulon, MD
|
|
| x | |
| 3:50 PM - 3:55 PM | Update On Embolic Brain Protection Devices And Techniques During TEVAR And TAVI: Do They Prevent Strokes Or DW-MRI Hits And When Will They Be Available In The US |
| Presenter(s):Jeffrey P. Carpenter, MD | |
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | Value Of TEVAR In Treating Chronic TBADs And Associated Aneurysms: It May Prevent Death But Often Requires Reintervention: How Can The Latter Be Prevented |
| Presenter(s):Matt M. Thompson, MD | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | Advanced CTAG Designs For Treating Complex Thoracic Aortic Lesions Close To The Arch Or With Tortuous Anatomy By TEVAR |
| Presenter(s):William J. Quinones-Baldrich, MD | |
| View Slides in PDF | |
| 4:08 PM - 4:14 PM | Panel Discussion |
| ADVANCES IN TREATMENT OF TAAAS | |
| 4:15 PM - 4:20 PM | Value Of Branched Endografts (From Cook) For Treating TAAAs: Lessons Learned, Long-Term Results, Advantages And Limitations |
| Presenter(s):Timothy A.M. Chuter, DM | |
| View Slides in PDF | |
| 4:21 PM - 4:26 PM | Value And Limitations Of Sandwich Grafts For Treating TAAAs: Technical Tips |
| Presenter(s):Armando C. Lobato, MD, PhD | |
| View Slides in PDF | |
| 4:27 PM - 4:32 PM | Gore Multibranched Tambe Off-The-Shelf (OTS) Device For Treating TAAAs: Technique And Early Experience |
| Presenter(s):Michel Makaroun, MD / Gustavo S. Oderich, MD FACS / Mark A. Farber, MD | |
| View Slides in PDF | |
| 4:33 PM - 4:38 PM | Valiant TAAA Device From Medtronic: Based On A Manifold Principle With Multiple Branches To Visceral, Renal And Iliac Arteries: Concept And Early Results With A Potentially OTS Device |
| Presenter(s):Patrick W. Kelly, MD | |
| View Slides in PDF | |
| 4:39 PM - 4:44 PM | When Should Endovascular Treatments Be Used With Marfan’s Patients And When Should They Not Be Used |
| Presenter(s):Ourania Preventza, MD / Joseph S. Coselli, MD | |
| View Slides in PDF | |
| 4:45 PM - 4:52 PM | Panel Discussion |
| END OF SESSION 7 | |
| SESSION 8 SCHEDULE | |
|
Tuesday
SESSION 8:
CONTROVERSY SURROUNDING TEVAR TREATMENT OF UNCOMPLICATED TBADs; OTHER TBAD AND TAAA TOPICS & ONE CAROTID TOPIC
Moderators:Carlos H. Timaran, MD / Matt M. Thompson, MD
|
|
| x | |
| 4:53 PM - 4:58 PM | Why Is There Such Disagreement On TEVAR Treatment For Uncomplicated TBAD |
| Presenter(s):Frank J. Criado, MD, FACS, FSVM | |
| View Slides in PDF | |
| 4:59 PM - 5:04 PM | DEBATE: Most Uncomplicated TBAD Patients Should Undergo TEVAR Since TEVAR Often Leads To False Lumen Thrombosis And Stability: We Do Not Need Further RCTs |
| Presenter(s):Christoph A. Nienaber, MD, PhD | |
| View Slides in PDF | |
| 5:05 PM - 5:10 PM | DEBATE: Not So, Many Uncomplicated TBAD Patients Should Be Treated Medically: TEVAR Treatment Should Be Selective And We Need More Trials |
| Presenter(s):Michel Makaroun, MD | |
| View Slides in PDF | |
| 5:11 PM - 5:16 PM | Why We Need Another Trial Comparing Medical Treatment Alone To Medical Treatment With Early TEVAR For Uncomplicated TBAD: What Is The Status Of Such A Trial |
| Presenter(s):Firas F. Mussa, MD | |
| View Slides in PDF | |
| 5:17 PM - 5:22 PM | What Are The In-Hospital Complications That Occur In Medically Treated Uncomplicated TBAD Patients (From IRAD): Can They Be Predicted And Do We Need More RCTs Examining Value And Timing Of TEVAR |
| Presenter(s):Santi Trimarchi, MD, PhD | |
| View Slides in PDF | |
| 5:23 PM - 5:28 PM | When Is Early TEVAR Indicated In Uncomplicated TBAD; What Are The Risks |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 5:29 PM - 5:34 PM | Why Shouldn’t All Acute TBAD Patients Be Treated With TEVAR: What Is The Best Timing For The Procedure And How To Distinguish Between “Acute” And “Chronic” TBAD |
| Presenter(s):Johnny Steuer, MD, PhD | |
| View Slides in PDF | |
| 5:35 PM - 5:40 PM | DEBATE: Long-Term Results Of Open Repair Of TAAAs: When Is Open Repair The Best Treatment And Who Should Be Doing It |
| Presenter(s):Hazim J. Safi, MD | |
| View Slides in PDF | |
| 5:41 PM - 5:46 PM | DEBATE: Long-Term Results Of Endovascular Repair Of TAAAs: When Is Open Repair Indicated |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 5:47 PM - 5:52 PM | Age, Contralateral ICA Occlusion And Time Since Symptom Onset Are Not Contraindications For CAS If Certain Precautions Are Taken |
| Presenter(s):Horst Sievert, MD | |
| View Slides in PDF | |
| 5:53 PM - 6:02 PM | Panel Discussion End of Program A |
| END OF SESSION 8 | |
| SESSION 9 SCHEDULE | |
|
Tuesday
SESSION 9:
NEW DEVELOPMENTS IN AAAs AND EVAR
Moderators:Enrico Ascher, MD / Ali F. AbuRahma, MD
|
|
| x | |
| 6:40 AM - 6:44 AM | Opening Remarks |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 6:45 AM - 6:50 AM | Indications For Open AAA Repair In The Current Advanced Endovascular Era |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 6:51 AM - 6:56 AM | All AAA Patients Who Need Invasive Treatment Should Be Treated By EVAR If They Have Suitable Anatomy: This Includes Young Patients: This Is Why |
| Presenter(s):Mark Conrad, MD, MMSc | |
| View Slides in PDF | |
| 6:57 AM - 7:02 AM | Propensity Matched Comparison Of EVAR vs. Open Repair In A Large US Medicare Database Show EVAR Benefits Up To 7 Years Later: Nevertheless, Open Repair Is Indicated In Young AAA Patients: This Is Why |
| Presenter(s):Marc L. Schermerhorn, MD | |
| View Slides in PDF | |
| 7:03 AM - 7:08 AM | Interesting Insights From The RCTs Comparing EVAR To Open Repair After 12-15 Years Of Follow-Up: EVAR Benefits Are Not Durable And Reinterventions Continue To Be Needed |
| Presenter(s):Hence J.M. Verhagen, MD, PhD / Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 7:09 AM - 7:14 AM | Long-Term Results Of EVAR With Standard AAA Endografts: How Do These Results Differ From Those In The EVAR RCTs And Why |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 7:15 AM - 7:20 AM | Are Advantages Of Lower AAA Related Mortality From EVAR vs. Open Repair Sustained Better With New Generation Devices: A Critical Comparison Of EVAR 1 vs. The ENGAGE Registry |
| Presenter(s):Dittmar Boeckler, MD | |
| View Slides in PDF | |
| 7:21 AM - 7:26 AM | Interesting Key Messages And Highlights From The 15-Year Results Of The EVAR 1 Trial Just Published In The Lancet |
| Presenter(s):Roger M. Greenhalgh, MD | |
| View Slides in PDF | |
| 7:27 AM - 7:33 AM | Panel Discussion |
| Moderator(s): Timur P. Sarac, MD / Gregg S. Landis, MD | |
| 7:33 AM - 7:38 AM | How To Enable EVAR To Be Done For AAAs With Neck Diameters >36 mm: A Combination Of An Endologix AFX Endograft And A Larger Diameter Valiant Tube Graft Makes It Feasible |
| Presenter(s):Jean-Paul de Vries, MD, PhD | |
| View Slides in PDF | |
| 7:39 AM - 7:44 AM | Value Of Hypnosis For EVAR And Other Endovascular Procedures To Make Them Even Less Invasive: How To Do It |
| Presenter(s):Jean-Pierre Becquemin, MD, FRCS | |
| View Slides in PDF | |
| 7:45 AM - 7:50 AM | How Are Long-Term EVAR Outcomes Impacted By Extremely Angled Necks, Conical Necks, And Necks With Circumferential Thrombus: It Doesn’t Seem To Matter If . . . |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 7:51 AM - 7:56 AM | Current Optimal Management Of Inflammatory AAAs: When Endo, When Open |
| Presenter(s):Franco Grego, MD | |
| View Slides in PDF | |
| 7:57 AM - 8:02 AM | Inflammatory AAAs: Open vs. Endo Treatment And Tips And Tricks For Safely Treating With Open Repair |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 8:03 AM - 8:08 AM | EVAR Techniques For Inflammatory AAAs And Other Rare AAAs Including Behçet’s Disease: How Effective And Durable Are They |
| Presenter(s):Furuzan Numan, MD | |
| View Slides in PDF | |
| 8:09 AM - 8:14 AM | Panel Discussion |
| END OF SESSION 9 | |
| SESSION 10 SCHEDULE | |
|
Tuesday
SESSION 10:
NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC BRANCH LESIONS – ESPECIALLY OF THE AORTO-ILIAC SEGMENT
Moderators:Kenneth Ouriel, MD, MBA / Barry T. Katzen, MD
|
|
| x | |
| 8:15 AM - 8:20 AM | What Proportion Of Aorto-Iliac Lesions Require Open Treatment: Tips And Tricks For Treating Endo |
| Presenter(s):Ali Amin, MD, RVT, FACS, FACC | |
| View Slides in PDF | |
| 8:21 AM - 8:26 AM | Endovascular Treatment Of Juxtarenal Aortic Occlusions: Technique Of Treatment And Renal And Visceral Protection: Midterm Results |
| Presenter(s):Sonia Ronchey, MD, PhD / Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 8:27 AM - 8:32 AM | 3-Year Results With The CERAB Procedure For Stent-Graft Reconstruction Of The Occluded Aortic Bifurcation: Technical Precautions, Advantages And Limitations |
| Presenter(s):Michel M.P. Reijnen, MD, PhD / Peter C.J. Goverde, MD | |
| View Slides in PDF | |
| 8:33 AM - 8:38 AM | How Can Chimney Grafts Be Used Effectively With The CERAB Procedure: Techniques And Results |
| Presenter(s):Peter C.J. Goverde, MD / Michel M.P. Reijnen, MD, PhD | |
| View Slides in PDF | |
| 8:39 AM - 8:44 AM | Endologix AFX EVAR Endograft For The Treatment Of Complex Aorto-Iliac Occlusive Disease: When Is It Indicated, How To Perform And Early Results |
| Presenter(s):Thomas S. Maldonado, MD | |
| View Slides in PDF | |
| 8:45 AM - 8:50 AM | Is There Still A Role For Open Aortofemoral Bypass For Aorto-Iliac Occlusive Disease: What Is It And Why |
| Presenter(s):Michael Belkin, MD | |
| View Slides in PDF | |
| HYPOGASTRIC ARTERY ISSUES | |
| 8:51 AM - 8:56 AM | At What Size Do Hypogastric Artery Aneurysms Rupture: At What Size Is Repair Indicated: Textbook Indications For Repair Should Change |
| Presenter(s):Maarit Venermo, MD, PhD | |
| View Slides in PDF | |
| 8:57 AM - 9:02 AM | What Should Be Done About Hypogastric Aneurysms Excluded Only Proximally By Overstenting: At What Size Should Something Else Be Done And What Is That Something |
| Presenter(s):Frans L. Moll, MD, PhD | |
| View Slides in PDF | |
| 9:03 AM - 9:08 AM | Comparison Of Available Iliac Branched Devices (IBDs) For Iliac Aneurysms And Hypogastric Revascularization: Advantages And Limitations Of Each |
| Presenter(s):Timothy A. Resch, MD, PhD | |
| View Slides in PDF | |
| 9:09 AM - 9:15 AM | Panel Discussion |
| 9:15 AM - 9:25 AM | Break - Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 10 | |
| SESSION 11 SCHEDULE | |
|
Tuesday
SESSION 11:
VASCULAR LAPAROSCOPY, SOME ROBOTICS AND NEW HELPFUL TECHNIQUES AND COMPARISONS
Moderators:Alan B. Lumsden, MD, FACS / Jean-Baptiste Ricco, MD, PhD
|
|
| x | |
| 9:25 AM - 9:30 AM | With New Developments In Laparoscopic Robotic Aortic Surgery, It May Still Have A Real Role In Vascular Treatment: Unlike My Impression Last Year |
| Presenter(s):Willem Wisselink, MD | |
| View Slides in PDF | |
| 9:31 AM - 9:36 AM | Advances In Laparoscopic Robotic Surgery Indicate It Has A Bright Future For Treating Aortic And Visceral Artery Disease: How The Gore Hybrid Graft Facilitates This |
| Presenter(s):Fabien Thaveau, MD, PhD | |
| View Slides in PDF | |
| 9:37 AM - 9:42 AM | Laparoscopic Aorto-Bifemoral Bypass: Indications And Advantages In An Endovascular World |
| Presenter(s):Joseph S. Giglia, MD | |
| View Slides in PDF | |
| 9:43 AM - 9:48 AM | Laparoscopic Aortic Surgery Has More Adverse Events Than Open Aortic Surgery: A Propensity Matched Comparison With Well-Trained Laparoscopic And Open Surgeons |
| Presenter(s):Jean-Baptiste Ricco, MD, PhD | |
| View Slides in PDF | |
| 9:49 AM - 9:54 AM | Endovascular Retroperitoneoscopic Technique Offers New Possibilities For Laparoscopic Aorto-Bifemoral Bypass In Complex TASC D Aorto-Iliac Lesions |
| Presenter(s):Bernard J. Segers, MD | |
| View Slides in PDF | |
| COMPARISONS AND NEW TECHNIQUES | |
| 9:55 AM - 10:00 AM | Comparison Of AAA Sac Shrinkage After Fenestrated EVAR (F/EVAR) And Standard EVAR: F/EVAR Wins |
| Presenter(s):Neal S. Cayne, MD | |
| View Slides in PDF | |
| 10:01 AM - 10:06 AM | Comparison Of Open Surgery, Hybrid Techniques And Fenestrated Or Branched EVAR (F/BEVAR) For TAAAs |
| Presenter(s):Piergiorgio Cao, MD, FRCS | |
| View Slides in PDF | |
| 10:07 AM - 10:12 AM | False Lumen Obliteration In Chronic TBADs Using An Inverted (“Flipped”) Cook Converter And Occlusion Plug |
| Presenter(s):Niten Singh, MD | |
| View Slides in PDF | |
| 10:13 AM - 10:19 AM | Panel Discussion |
| END OF SESSION 11 | |
| SESSION 12 SCHEDULE | |
|
Tuesday
SESSION 12:
NEW DEVELOPMENTS WITH JUXTA AND PARARENAL AORTIC ANEURYSMS AND THORACOABDOMINAL ANEURYSMS (TAAAs)
Moderators:Kim J. Hodgson, MD / Giovanni Torsello, MD
|
|
| x | |
| 10:20 AM - 10:25 AM | Current Status Of The Only FDA Approved Fenestrated Graft (ZFEN From Cook) That Is Commercially Available In The US: How Is Its General Adoption Doing |
| Presenter(s):Andres Schanzer, MD | |
| View Slides in PDF | |
| 10:26 AM - 10:31 AM | With ZFEN F/EVAR, A Large SMA Scallop Can Cause Problems: What Are They And What Is The Solution |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| HOSTILE AAA NECKS | |
| 10:32 AM - 10:37 AM | What Is A Hostile Infrarenal Neck And When Should F/EVAR Be Done Rather Than Standard EVAR |
| Presenter(s):Matthew J. Eagleton, MD | |
| View Slides in PDF | |
| 10:38 AM - 10:43 AM | When Can Standard EVAR Be Safely And Durably Performed In Patients With Hostile Necks |
| Presenter(s):Hence J.M. Verhagen, MD, PhD | |
| View Slides in PDF | |
| 10:44 AM - 10:49 AM | In Most AAA Patients With Hostile Necks F/EVAR Is The Best Treatment: What Are The Exceptions |
| Presenter(s):Marcelo Ferreira, MD | |
| View Slides in PDF | |
| 10:50 AM - 10:55 AM | In Most Patients With Hostile Necks Chimney EVAR (Ch/EVAR) Is The Best Treatment: What Are The Exceptions |
| Presenter(s):Giovanni Torsello, MD / Konstantinos P. Donas, MD / Jason T. Lee, MD | |
| View Slides in PDF | |
| 10:56 AM - 11:01 AM | When Does Hybrid Endovascular Repair With Renal And Visceral Debranching Have A Role In Treating TAAAs: Patient Selection And Technical Tips |
| Presenter(s):Martin R. Back, MD | |
| View Slides in PDF | |
| 11:02 AM - 11:08 AM | Panel Discussion |
| Moderator(s): James F. McKinsey, MD / Piergiorgio Cao, MD, FRCS | |
| 11:08 AM - 11:13 AM | Prevention Of Visceral And Renal Branch Artery Complications During F/BEVAR: Selection Of The Optimal Bridging Stent-Graft |
| Presenter(s):Darren B. Schneider, MD | |
| View Slides in PDF | |
| F/EVAR FOR FAILED EVAR | |
| 11:14 AM - 11:19 AM | F/EVAR Cuffs vs. Ch/EVAR For Failed Standard EVAR: Indications, Advantages And Limitations Of Each |
| Presenter(s):Bijan Modarai, PhD, FRCS | |
| View Slides in PDF | |
| 11:20 AM - 11:25 AM | F/EVAR For Failed Standard EVAR: When Is It Indicated And When Must Open Repair Be Done |
| Presenter(s):Cherrie Z. Abraham, MD | |
| View Slides in PDF | |
| 11:26 AM - 11:31 AM | Midterm Results Of Chimney Grafts For Pararenal AAAs: How To Make Them Work |
| Presenter(s):Nicola Mangialardi, MD | |
| View Slides in PDF | |
| 11:32 AM - 11:37 AM | Adjuncts To Improve Outcomes Of Treatment For Challenging (Juxta And Pararenal) AAAs: Parallel Grafts, Endoanchors, New Endografts, Better Imaging, Simulation: Are They All Essential Or Not |
| Presenter(s):Isabelle van Herzeele, MD, PhD | |
| View Slides in PDF | |
| 11:38 AM - 11:43 AM | Open Repair vs. Branched EVAR (B/EVAR) For Type IV TAAAs: When To Do Each And How Iliac Anatomy Influences Choice: B/EVAR Results |
| Presenter(s):Andrea Stella, MD | |
| View Slides in PDF | |
| 11:44 AM - 11:49 AM | The COLT Endograft System For Treatment Of TAAAs: A Novel Simplified Endograft System From Jotec: How It Works: What Makes It Different And Early Clinical Results |
| Presenter(s):Piotr Szopinski, MD | |
| View Slides in PDF | |
| 11:50 AM - 12:00 PM | Panel Discussion |
| 12:00 PM - 1:00 PM | Lunch Break - 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 12 | |
| SESSION 13 SCHEDULE | |
|
Tuesday
SESSION 13:
BUSINESS ISSUES, NEW CONCEPTS
Moderators:Richard J. Powell, MD / Enrico Ascher, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | Value, Limitations And Abuses Of Outpatient Angio Centers: How To Limit Abuses |
| Presenter(s):Stephen M. Bauer, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Massive Use Of Atherectomy In Outpatient Facilities Is Self-Serving And Does Not Help Patients |
| Presenter(s):Dipankar Mukherjee, MD | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Whole Food Plant Based Nutrition As A Method To Prevent And Reverse Atherosclerosis And Its Consequences: How To Do It Effectively In An Outpatient Setting |
| Presenter(s):Sam S. Ahn, MD, FACS, MBA | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | When Is Outpatient Treatment Justified For Peripheral Occlusive Lesions: Precautions And Techniques |
| Presenter(s):Enrico Ascher, MD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | How To Create A Medical Company Start-Up And Keep It: Creating A Corporation, Getting Funding, Value Of A Business Plan And More |
| Presenter(s):Timothy K. Liem, MD, MBA | |
| View Slides in PDF | |
| ISSUES AND NEW CONCEPTS | |
| 1:30 PM - 1:35 PM | When Is Enough Enough With Endovascular Options: Why Open Surgery Will Never Die |
| Presenter(s):Krishna Jain, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Endojunk And Its Management: What To Do With Materials Left In Situ Unintentionally During EVAR And TEVAR |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | The Piculet Recanalization Device For Crossing Difficult CTOs: How It Works And When Is It Indicated |
| Presenter(s):Yann Gouëffic, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Intraoperative Arterial Quantitative Flow Measurements With The Medistem Vascular Flow Device: How Does It Work And Can It Help With Intraoperative Decisions And Postoperative Assessment |
| Presenter(s):Tej M. Singh, MD, MBA | |
| View Slides in PDF | |
| 1:54 PM - 2:00 PM | Panel Discussion |
| END OF SESSION 13 | |
| SESSION 14 SCHEDULE | |
|
Tuesday
SESSION 14:
MORE NEW TECHNIQUES, CONCEPTS AND UPDATES
Moderators:Sean P. Lyden, MD / Caron B. Rockman, MD
|
|
| x | |
| 2:00 PM - 2:05 PM | Value Of Phoenix 2.2 mm Atherectomy System (From Volcano) In Treating Lower Extremity Occlusive Lesions: It Cuts, Captures And Clears In 1 Step: How Does It Work And Early Results |
| Presenter(s):Luis R. Leon, MD, RVT, FACS | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Superior Mesenteric Artery (SMA) Reimbplantation For The Nutcracker Syndrome With Duodenal Obstruction: A Better Treatment Than Gastrojejunostomy |
| Presenter(s):Kenneth J. Cherry, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | How To Make Thrombolysis More Precise And Effective With Microbubbles And EKOS Catheters: Results In Humans From The MUST Trial |
| Presenter(s):Kak Khee Yeung, MD, PhD | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | Value Of Ultrasound In The Operating Room In Planning, Access, Control Of Angioplasty Above And Below The Knee (BTK) And Closure Of The Puncture Site |
| Presenter(s):Enrique Puras, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Pioneering Techniques For The Endovascular Treatment Of Critical Upper Extremity Ischemia With Gangrene |
| Presenter(s):Roberto Ferraresi, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Update On The Current Status Of Stem Cell And Bone Marrow Therapy For CLI And Gangrene With Unfixable Distal Arteries |
| Presenter(s):Richard J. Powell, MD | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Two Techniques To Facilitate F/BEVAR: 1) The Up-And-Over Technique For Endoconduit Solutions With Bad Iliac Access Arteries And 2) Progressive Main Graft Deployment With Sequential Branch Catheterization And Stent-Grafting To Permit Staging And To Deal With Narrow Aortas |
| Presenter(s):Carlos H. Timaran, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:47 PM | Physiological And Biomechanical Information From 4D Dynamic Imaging Can Help Us Understand And Guide The Management Of Aortic Disease: New Developments |
| Presenter(s):Rachel E. Clough, MD, PhD | |
| View Slides in PDF | |
| 2:48 PM - 2:53 PM | Radial Access For Most Non-Coronary Interventions: Equipment, Techniques, Advantages, Risks And Limitations |
| Presenter(s):Marcelo Guimaraes, MD, FSIR | |
| View Slides in PDF | |
| 2:54 PM - 2:59 PM | Value And Advantages Of The Chocolate Balloon PTA Catheter (TriReme/Cordis): Theory Of Its Pillows And Groove Technology And Clinical Results (The ENDURE Trial) |
| Presenter(s):Andrew Holden, MBChB / Jihad A. Mustapha, MD | |
| View Slides in PDF | |
| 3:00 PM - 3:20 PM | Panel Discussion And Break Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 14 | |
| SESSION 15 SCHEDULE | |
|
Tuesday
SESSION 15:
RENAL AND VISCERAL ARTERY ISSUES AND NEW DEVELOPMENTS
Moderators:Kim J. Hodgson, MD / Keith D. Calligaro, MD
|
|
| x | |
| 3:20 PM - 3:25 PM | Pancreaticoduodenal And Gastroduodenal Aneurysms: Indications And Precautions For Treatment And Which Is Best – Open vs. Endo |
| Presenter(s):James C. Stanley, MD | |
| View Slides in PDF | |
| 3:26 PM - 3:31 PM | Pancreaticoduodenal Aneurysms: Technical Tips And Tricks For Open Repair |
| Presenter(s):Ronald M. Fairman, MD | |
| View Slides in PDF | |
| 3:32 PM - 3:37 PM | Visceral Artery Aneurysms: When And At What Size Are They Dangerous And How Should They Be Fixed |
| Presenter(s):Armando Mansilha, MD, PhD, FEBVS | |
| View Slides in PDF | |
| 3:38 PM - 3:43 PM | With Visceral And Renal Artery Aneurysms An Endovascular First Strategy Is Best For All Intact And Ruptured Cases: Are There Exceptions |
| Presenter(s):Rabih A. Chaer, MD | |
| View Slides in PDF | |
| 3:44 PM - 3:49 PM | Incidence Of Embolization In Association With F/BEVAR: Is Late Renal Salvage After Renal Artery Occlusion Possible And What Is The Mechanism |
| Presenter(s):James F. McKinsey, MD | |
| View Slides in PDF | |
| 3:50 PM - 3:55 PM | DCBs (In.Pact Admiral) Are A Better Treatment For Renal In Stent Restenosis (ISR) And Fibromuscular Hyperplasia |
| Presenter(s):Plinio Rossi, MD / Fabrizio Fanelli, MD, EBIR | |
| View Slides in PDF | |
| 3:56 PM - 4:01 PM | Remedial Operations For Failed Endovascular Treatments On Pediatric Renal Arteries |
| Presenter(s):Jonathan L. Eliason, MD / James C. Stanley, MD | |
| View Slides in PDF | |
| 4:02 PM - 4:07 PM | What Is The Best Current Treatment For Mesenteric Ischemia; When Endo, When Open, When Hybrid: Based On Outcomes |
| Presenter(s):Timur P. Sarac, MD | |
| View Slides in PDF | |
| 4:08 PM - 4:13 PM | Retrograde SMA Revascularization Via Celiac Artery And Collaterals When Antegrade Techniques Fail: Technical Tips |
| Presenter(s):Timothy A. Resch, MD, PhD / Nuno Dias, MD | |
| View Slides in PDF | |
| 4:14 PM - 4:19 PM | Variably Curved Conformable Sheaths (Oscor Twist) Make A Major Difference In Endovascular Procedures: Like SMA Stenting From A Femoral Approach And Fenestrated And Branched EVAR |
| Presenter(s):Joshua D. Adams, MD / Claudio J. Schonholz, MD | |
| View Slides in PDF | |
| 4:20 PM - 4:25 PM | The Renal Guard Device To Prevent Contrast Induced Renal Injury In High Risk Patients: How Does It Work And Is It Effective |
| Presenter(s):Kolja Sievert, MD / Horst Sievert, MD | |
| View Slides in PDF | |
| 4:26 PM - 4:32 PM | Panel Discussion |
| END OF SESSION 15 | |
| SESSION 16 SCHEDULE | |
|
Tuesday
SESSION 16:
TOPICS RELATED TO OPEN SURGERY AND AORTIC COARCTATIONS
Moderators:Fred A. Weaver, MD / Ronald M. Fairman, MD
|
|
| x | |
| 4:32 PM - 4:37 PM | Status Of Balloon Expandable Stents And Stent-Grafts (Atrium V12 LD) For Treatment Of Aortic Coarctation: Results Of The COAST I And II Trials |
| Presenter(s):Elchanan Bruckheimer, MBBS | |
| View Slides in PDF | |
| 4:38 PM - 4:43 PM | Long-Term Outcome Of Celiac Trunk Release For Celiac Axis Compression Syndrome: When Does The Artery Have To Be Treated And Open Surgery Is Best |
| Presenter(s):Willem Wisselink, MD / Jan D. Blankensteijn, MD | |
| View Slides in PDF | |
| 4:44 PM - 4:49 PM | Open Surgery Is The Best Treatment For Coral Reef Lesions Of The Aorta And Visceral And Iliac Arteries: How To Diagnose Them And Why Endo Treatments Are No Good |
| Presenter(s):Laurent Chiche, MD | |
| View Slides in PDF | |
| 4:50 PM - 4:55 PM | Tips And Tricks For Open Repair Of TAAAs As Primary Procedures And After Failed Endo Procedures: Including Use Of Sutureless Hybrid Graft (Gore) For Renal Revascularization |
| Presenter(s):Roberto Chiesa, MD / Yamume Tshomba, MD | |
| View Slides in PDF | |
| 4:56 PM - 5:01 PM | Indications For Open TAAA Repair In The Endovascular Era |
| Presenter(s):Hazim J. Safi, MD / Anthony L. Estrera, MD | |
| View Slides in PDF | |
| 5:02 PM - 5:07 PM | Role Of Ascending Aorta To Supra-Aortic Trunk Bypasses In The Endovascular Era: Technical Precautions And Tips |
| Presenter(s):John E. Rectenwald, MD, MS | |
| View Slides in PDF | |
| 5:08 PM - 5:14 PM | Panel Discussion |
| Moderator(s): R. Clement Darling III, MD / James H. Black, III, MD | |
| 5:14 PM - 5:19 PM | Treatment Of Post TEVAR Aorto-Esophageal Fistula: Only Radical Surgery Can Prevent Patient Mortality: Steps In The Operative Treatment |
| Presenter(s):Michael J. Jacobs, MD | |
| View Slides in PDF | |
| 5:20 PM - 5:25 PM | Distal Aortic Failure After TEVAR: When Is Open Repair Best And Tips And Tricks To Do It |
| Presenter(s):James H. Black, III, MD | |
| View Slides in PDF | |
| 5:26 PM - 5:31 PM | What Is The Role Of Aorto-Bifemoral Bypass For Aorto-Iliac Occlusive Disease In The Current Endovascular Era |
| Presenter(s):Mr. Michael G. Wyatt, MD | |
| View Slides in PDF | |
| 5:32 PM - 5:37 PM | Value Of Hybrid Techniques For Treating Difficult CLI Patients: Advantages And Techniques |
| Presenter(s):Carlo Setacci, MD | |
| View Slides in PDF | |
| 5:38 PM - 5:43 PM | What Is The Role Of Open Surgical Distal Lower Extremity Bypass In The Current Endovascular Era |
| Presenter(s):R. Clement Darling III, MD | |
| View Slides in PDF | |
| 5:44 PM - 5:49 PM | After Multiple Failed Endovascular Treatments, Open Bypasses Can Save Limbs |
| Presenter(s):Julien G. Sfeir, MD | |
| View Slides in PDF | |
| 5:50 PM - 5:58 PM | Panel Discussion End of Program B |
| END OF SESSION 16 | |
| SESSION 17 SCHEDULE | |
| x | |
| 7:00 AM - 7:10 AM | Introduction To The Symposium |
| Presenter(s):Frank J. Veith, MD | |
| View Slides in PDF | |
| 7:10 AM - 7:15 AM | The Basics Of Pulmonary Embolism: What Is The Role Of The History, Exam, Biomarkers |
| Presenter(s):Raghu Kolluri, MD | |
| View Slides in PDF | |
| 7:25 AM - 7:35 AM | What Does The CT For PE Actually Tell Us |
| Presenter(s):Brian B. Ghoshhajra, MD, MBA | |
| View Slides in PDF | |
| 7:35 AM - 7:50 AM | What Is State-Of-The-Art Medical Therapy For PE |
| Presenter(s):Geno J. Merli, MD, MACP, FHM, FSVM | |
| View Slides in PDF | |
| 7:50 AM - 8:00 AM | Just Tell Me What I Need To Know: When Do I Look For Cancer And Perform Hypercoagulable Tests In PE |
| Presenter(s):Rachel Rosovsky, MD, MPH | |
| View Slides in PDF | |
| 8:00 AM - 8:10 AM | Setting The Stage: The Emergency Physician Algorithm For Acute PE Management |
| Presenter(s):D. Mark Courtney, MD | |
| View Slides in PDF | |
| 8:10 AM - 8:25 AM | Intravenous Thrombolytic Therapy For PE: Does It Actually Work, And Safely |
| Presenter(s):Mitchell D. Weinberg, MD | |
| View Slides in PDF | |
| 8:25 AM - 8:35 AM | Catheter-Directed Thrombolysis For PE: What Are The Outcomes |
| Presenter(s):Divya Sridhar, MD | |
| View Slides in PDF | |
| 8:35 AM - 8:45 AM | Percutaneous Pharmacomechanical Intervention For PE: Is There A Rationale |
| Presenter(s):Gary M. Ansel, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 8:45 AM - 9:15 AM | Case Presentations/Discussion/Questions and Answers |
| Panelist(s): Raghu Kolluri, MD / Brian B. Ghoshhajra, MD, MBA / Geno J. Merli, MD, MACP, FHM, FSVM / Rachel Rosovsky, MD, MPH / D. Mark Courtney, MD / Mitchell D. Weinberg, MD / Divya Sridhar, MD / Gary M. Ansel, MD | |
| View Slides in PDF | |
| 9:15 AM - 9:45 AM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 17 | |
| SESSION 18 SCHEDULE | |
| x | |
| 9:45 AM - 9:55 AM | Technical Tips For Pharmacomechanical Intervention For PE: How Do I Do It |
| Presenter(s):Michael Engelhardt, MD | |
| View Slides in PDF | |
| 9:55 AM - 10:05 AM | Pulmonary Embolism Intervention With Angiojet |
| Presenter(s):Jeffrey Y. Wang, MD | |
| View Slides in PDF | |
| 10:05 AM - 10:15 AM | Vortex Strategy For Massive PE |
| Presenter(s):Christopher J. Kwolek, MD | |
| View Slides in PDF | |
| 10:15 AM - 10:30 AM | ECMO And Surgical Thromboembolectomy For Massive PE: When, How And Why |
| Presenter(s):Georges M. Haidar, MD / Mark G. Davies, MD | |
| View Slides in PDF | |
| 10:30 AM - 10:45 AM | What Is The Modern Algorithm For Management Of Massive And Submassive PE |
| Presenter(s):Ido Weinberg, MD, MSc | |
| View Slides in PDF | |
| 10:45 AM - 11:00 AM | Vena Cava Filters In PE Treatment: Do We Need To Do This, And If So, When |
| Presenter(s):Amy R. Deipolyi, MD, PhD | |
| View Slides in PDF | |
| 11:00 AM - 11:15 AM | Balloon Angioplasty For Chronic Thromboembolic Pulmonary Hypertension: Is This Crazy |
| Presenter(s):Ehtisham Mahmud, MD | |
| View Slides in PDF | |
| 11:15 AM - 11:30 AM | The Team Approach To PE Management: The Emergence Of National PERT Centers |
| Presenter(s):Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| Moderator(s): Michael R. Jaff, DO | |
| 11:30 AM - 11:45 AM | Challenging Cases And “PERT” Decisions |
| Panelist(s): Tod C. Engelhardt, MD / Jeffrey Y. Wang, MD / Christopher J. Kwolek, MD / Mark G. Davies, MD / Ido Weinberg, MD, MSc / Amy R. Deipolyi, MD, PhD / Ehtisham Mahmud, MD / Kenneth Rosenfield, MD | |
| View Slides in PDF | |
| 11:45 AM - 12:00 PM | Questions and Answers |
| 12:00 PM - 1:00 PM | Lunch Break – 2nd Floor Promenade Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 18 | |
| SESSION 19 SCHEDULE | |
|
Tuesday
SESSION 19:
THE RECENT EXPLOSION IN VENOUS INTERVENTIONAL TECHNOLOGIES: NEW OPPORTUNITIES FOR THE PATIENT
Moderators:Kenneth Ouriel, MD, MBA / Peter Gloviczki, MD
|
|
| x | |
| 1:00 PM - 1:05 PM | The Transformation Of Venous Therapy: From Observation, Stockings And Medicines To Endovenous Interventions And Beyond |
| Presenter(s):Peter Gloviczki, MD | |
| View Slides in PDF | |
| 1:06 PM - 1:11 PM | Natural History Of Iliofemoral Venous Thrombosis: Does It Justify Aggressive Intervention? Which Patients And When? |
| Presenter(s):Nicos Labropoulos, BSc (Med), PhD, DIC, RVT | |
| View Slides in PDF | |
| 1:12 PM - 1:17 PM | Diagnostic Biomarkers In Venous Thromboembolism |
| Presenter(s):Thomas W. Wakefield, MD | |
| View Slides in PDF | |
| 1:18 PM - 1:23 PM | The Failing And Failed AV Access: Routine Interrogation Of The Central Veins With IVUS |
| Presenter(s):Rick De Graaf, MD, PhD | |
| View Slides in PDF | |
| 1:24 PM - 1:29 PM | When And How To Treat Iliofemoral Venous Obstruction Continuing Into The IVC |
| Presenter(s):David L. Gillespie, MD | |
| View Slides in PDF | |
| 1:30 PM - 1:35 PM | Office-Based Venous Stenting For Octogenarians |
| Presenter(s):Anil P. Hingorani, MD | |
| View Slides in PDF | |
| 1:36 PM - 1:41 PM | Chronic Venous Ulcers: Diagnostic And Therapeutic Strategies To Improve Outcome |
| Presenter(s):Manj S. Gohel, MD, FRCS, FEBVS | |
| View Slides in PDF | |
| 1:42 PM - 1:47 PM | Gaging Outcome After Venous Interventions: Anatomy Isn’t Everything, Current And New Quality Of Life Measures |
| Presenter(s):Cees H.A. Wittens, MD, PhD | |
| View Slides in PDF | |
| 1:48 PM - 1:53 PM | Recent Approval Of Payment For Outpatient IVUS: Has It Driven Changes In Practice Patterns |
| Presenter(s):Sean P. Roddy, MD | |
| View Slides in PDF | |
| 1:54 PM - 1:59 PM | Panel Discussion |
| END OF SESSION 19 | |
| SESSION 20 SCHEDULE | |
|
Tuesday
SESSION 20:
ACUTE DVT: ENDOVASCULAR INTERVENTIONS AND PHARMACOLOGIC REGIMENS
|
|
| x | |
| 2:00 PM - 2:05 PM | What Is The Proper Duration Of Anticoagulation For DVT |
| Presenter(s):Anthony J. Comerota, MD, FACS, FACC | |
| View Slides in PDF | |
| 2:06 PM - 2:11 PM | Thrombolysis For Acute DVT In A Tertiary Care Setting: Where Have We Been, Current Concepts, And Predictions For The Future |
| Presenter(s):Brian G. DeRubertis, MD | |
| View Slides in PDF | |
| 2:12 PM - 2:17 PM | Novel Oral Anticoagulation (NOACs) Dramatically Alter How We Treat Patients With Venous Disease |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 2:18 PM - 2:23 PM | The Utility Of Ultrasound-Enhanced Thrombolysis For Acute And Chronic DVT And An Update From The ACCESS Study |
| Presenter(s):Mark J. Garcia, MD | |
| View Slides in PDF | |
| 2:24 PM - 2:29 PM | Vacuum-Assisted Venous Thrombectomy: Where, When, How And Do We Need Anything More |
| Presenter(s):David J. Dexter, MD | |
| View Slides in PDF | |
| 2:30 PM - 2:35 PM | Use Of The Indigo Device For Acute DVT: Replacing Thrombus Dissolution With Thrombus Extraction |
| Presenter(s):Patrick E. Muck, MD, FACS | |
| View Slides in PDF | |
| 2:36 PM - 2:41 PM | Open Venous Thrombectomy: It Is Still Necessary In Some Patients |
| Presenter(s):Elna M. Masuda, MD | |
| View Slides in PDF | |
| 2:42 PM - 2:50 PM | Panel |
| 2:50 PM - 3:15 PM | Break – Visit Exhibits And Pavilions (2nd and 3rd Floors) |
| END OF SESSION 20 | |
| SESSION 21 SCHEDULE | |
|
Tuesday
SESSION 21:
NEW DEVICES AND IMAGING TECHNOLOGIES TO ACHIEVE SUPERIOR OUTCOMES IN TREATING LARGE VEIN OBSTRUCTION
Moderators:Enrico Ascher, MD / Cees H.A. Wittens, MD, PhD
|
|
| x | |
| 3:16 PM - 3:21 PM | Multicenter Experience With The Cook TriForce Device To Cross Large Vein Obstructions |
| Presenter(s):Jean Bismuth, MD | |
| View Slides in PDF | |
| 3:22 PM - 3:27 PM | DEBATE: We Need Venous Stents For Venous Disease: Arterial Stents Just Won’t Cut It |
| Presenter(s):Stephen A. Black, MD | |
| View Slides in PDF | |
| 3:28 PM - 3:33 PM | DEBATE: Marketed Stents Designed For Arteries Are More Than Adequate For Treating Venous Disease |
| Presenter(s):Mark J. Garcia, MD | |
| View Slides in PDF | |
| 3:34 PM - 3:39 PM | Comparison Of The Veniti VICI Stent And The Wallstent: Anatomy And Physiology In An Animal Model |
| Presenter(s):William A. Marston, MD | |
| View Slides in PDF | |
| 3:40 PM - 3:45 PM | Shortcomings With Current Stents For May-Thurner Lesions: An Oblique Stent Is Needed |
| Presenter(s):Rick De Graaf, MD, PhD | |
| View Slides in PDF | |
| 3:46 PM - 3:51 PM | One-Year Results From The Feasibility Phase Of The Veniti VIRTUS Trial |
| Presenter(s):Lowell S. Kabnick, MD, RPhS, FACS, FACPh | |
| View Slides in PDF | |
| 3:52 PM - 3:57 PM | Long-Term Experience With The Cook Zilver Vena Stent |
| Presenter(s):Gerard J. O'Sullivan, MD | |
| View Slides in PDF | |
| 3:58 PM - 4:03 PM | Balloon Angioplasty Alone Is Inadequate For Iliac Vein Stenoses |
| Presenter(s):Anil P. Hingorani, MD | |
| View Slides in PDF | |
| 4:04 PM - 4:09 PM | What To Do When Inflow Is Needed For Iliofemoral Venous Stenting: The Role Of Endophlebectomy |
| Presenter(s):Ramesh K. Tripathi, MD, FRCS, FRACS | |
| View Slides in PDF | |
| 4:10 PM - 4:15 PM | Panel Discussion |
| Moderator(s): Kenneth Ouriel, MD, MBA / Paul J. Gagne, MD | |
| 4:16 PM - 4:21 PM | Veins Are Not Round: Diagnostic And Stenting Implications Of Elliptical Structures |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 4:22 PM - 4:27 PM | Shortcomings Of Venography And The Use Of IVUS In Venous Stenting: The VIDIO Study |
| Presenter(s):Paul J. Gagne, MD | |
| View Slides in PDF | |
| 4:28 PM - 4:33 PM | 3-Dimensional Imaging For Iliofemoral Obstruction: MRV And CTV |
| Presenter(s):Jean Bismuth, MD | |
| View Slides in PDF | |
| 4:34 PM - 4:39 PM | 2-D Perfusion Imaging For Iliofemoral Venous Obstruction |
| Presenter(s):Rick De Graaf, MD, PhD | |
| View Slides in PDF | |
| 4:40 PM - 4:45 PM | Sizing Venous Stents With IVUS: You Don’t Need To Be A Euclidean Geometrician |
| Presenter(s):Kenneth Ouriel, MD, MBA | |
| View Slides in PDF | |
| 4:46 PM - 4:51 PM | Duplex Ultrasound For Iliofemoral Venous Obstruction And Follow-Up After Stenting |
| Presenter(s):Michael R. Jaff, DO | |
| View Slides in PDF | |
| 4:52 PM - 4:59 PM | Panel Discussion |
| END OF SESSION 21 | |
| SESSION 22 SCHEDULE | |
|
Tuesday
SESSION 22:
MY WORST VENOUS DISASTER OF 2016: RAPID-FIRE PRESENTATION OF RESCUES AND LESSONS LEARNED
|
|
| x | |
| 5:00 PM - 5:04 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Gerard J. O'Sullivan, MD | |
| View Slides in PDF | |
| 5:05 PM - 5:09 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Robert A. Lookstein, MD, FSIR, FAHA | |
| 5:10 PM - 5:14 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Stephen A. Black, MD | |
| View Slides in PDF | |
| 5:15 PM - 5:19 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Rick De Graaf, MD, PhD | |
| View Slides in PDF | |
| 5:20 PM - 5:24 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Mark H. Meissner, MD | |
| View Slides in PDF | |
| 5:25 PM - 5:29 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Erin H. Murphy, MD | |
| View Slides in PDF | |
| 5:30 PM - 5:34 PM | My Worst Venous Disaster Of 2016: Rescues And Lessons Learned |
| Presenter(s):Paul J. Gagne, MD | |
| View Slides in PDF | |
| 5:35 PM - 5:45 PM | Panel Discussion End of Program C |
| END OF SESSION 22 | |